SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Ernexa Therapeutics Inc.
@ERNA_InsiderForm 4 Filing: Bristol James Arthur Acquires (Grant) shares of $ERNA
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Ernexa Therapeutics Inc.
Ticker: $ERNA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-31
Shares: 13,403
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bristol James Arthur, holds the title of Director at Ernexa Therapeutics Inc..
On 2026-08-31, the insider transacted 13,403 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bristol James Arthur (Director) was granted $0 of $ERNA
Post-Transaction Position: 8,320 shares
SEC Accession No: 0001493152-26-041137 (CIK: 1715153)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.